
Muslim, Lifelong learner⚕️Interventional FIT @medStarGUH, former chief cardiology @Creighton, former advanced🫀imaging @universityofky, 🟩 🇱🇾 Posts are my own
Omaha, NE
Joined December 2012
- Tweets2K
- Following2K
- Followers1K
- Likes3.1K
Pinned Tweet
Excited to share our latest review on novel therapies and techniques to improve saphenous vein graft longevity after CABG.
Grateful to collaborate with an outstanding team.
@CRMjournal @MedStarGUH @CRT_meeting @MedStarResearch
#cardiology
Review in @CRMjournal provides a comprehensive overview of novel therapies, techniques, and strategies to improve saphenous vein graft longevity after CABG. @wabusnina @KalChitturi @IAmDoctorAbhi @VermaBeniRai @jgalo92 @DorBen @HashimHayder @ronwaksman
sciencedirect.com/science/ar…
Waiel Abusnina (وائل أبوسنينة) retweeted
Slow flow and no reflow remain major unresolved challenges after PCI, particularly in STEMI.
Discover our State-of-the-Art review by @sbrugaletta et al exploring the mechanisms, diagnosis, and current treatment strategies
eurointervention.pcronline.c…
#STEMI #PCI #NoReflow #InterventionalCardiology
Our study in @ccijournal evaluates myocarditis trends @MedStarHealth during the pre-, peri-, and post-COVID eras.
Marked rise in myocarditis during the pandemic, rates remained elevated even in the post-pandemic period compared with pre-COVID levels.
onlinelibrary.wiley.com/doi/…
Live case from @MedStarWHC with @HashimHayder Tackling a difficult ISR case due to a calcified nodule. All this information being obtained from #IVUS Further, AI technology with @BSCCardiology ALA allows for precise lesion/vessel measurements @CRT_meeting @GiorgioMedranda
Our analysis in @AmJCardio from @MedStarHealth shows that IV cangrelor was used in higher-acuity, high–bleeding risk patients. Despite this risk profile, ischemic outcomes were similar, and cangrelor use was not associated with increased major bleeding.
pubmed.ncbi.nlm.nih.gov/4176…
Waiel Abusnina (وائل أبوسنينة) retweeted
Wow!!!
91M Stuck 1.25mm burr mRCA retrieved with…
GEC ❌
2nd access
➡️ NC ❌
➡️ IVL ❌
➡️ Second rota (!) 1.5mm ❌
➡️ OAS ✅
Audience in shock! Well done Dr Nakao and colleagues 🇯🇵😅 @esbrilakis @DrPeterOKane @DrPrimeroNg @mmamas1973 #TCT2025
Waiel Abusnina (وائل أبوسنينة) retweeted
Our analysis published in @AmJCardio demonstrating that Cangrelor as an ad-hoc bailout strategy is safe, feasible, and may provide an alternative to GP IIb/IIIa. @IAmDoctorAbhi @andrew_p_hill @wabusnina @lior_lupu @DorBen @HashimHayder @ron_waksman
pubmed.ncbi.nlm.nih.gov/4069…
Waiel Abusnina (وائل أبوسنينة) retweeted
Now out in @AmJCardio: Our study reveals major geographic gaps in intracoronary imaging use during PCI across 🇺🇸— underscoring the need for more equitable adoption.
Grateful to Drs. #GaryMintz, @ron_waksman & my colleagues for their support!
Read here 📖 rebrand.ly/91db41
Waiel Abusnina (وائل أبوسنينة) retweeted
Are you familiar with the use of the MANTA closure device as a bailout strategy for large-bore femoral access closure?
A key limitation to MANTA use in this setting is the lack of common femoral artery depth measurement, which is essential for safe device deployment.
📢 We have just published our study in CCI Journal on the use of MANTA as a bailout strategy for large-bore femoral access closure.
🔗 doi.org/10.1002/ccd.31661
In this study, we show that CT-derived depth measurements demonstrate strong agreement and correlation with the MANTA Depth Locator. This supports the use of preprocedural CT (readily available in nearly all TAVR patients) or pre-decannulation CT in MCS patients to enable safe MANTA bailout when no prior depth was recorded.
📊 We also provide a comprehensive review of the literature and propose a practical algorithm to guide MANTA bailout use based on clinical scenarios and the available tools in the cath lab.
Warm thanks to my amazing co-authors for their invaluable support and collaboration throughout this project. To Dr. Itsik Ben-Dor and Dr. @ronwaksman for their mentoring and guidance; to Dr. @andrew_p_hill for his exceptional assistance with the CT analysis and manuscript. To Dr. Matteo Cellamare, Dr. Cheng Zhang, and Dr. Vaishnavi Sawant, for their support with data management and statistical analysis; to Dr. @KalChitturi for his editorial support; to Dr. Toby Rogers, Dr. @haberdan, Dr. Lowell Satler, Dr. @IAmDoctorAbhi, and Dr. @wabusnina, for their contributions to the manuscript and their invaluable guidance.
Waiel Abusnina (وائل أبوسنينة) retweeted
Study protocol in the figure..PROTECT IV is a highly anticipated trial that will impact practice
Q will it be powered for superiority❓@CRMjournal
sciencedirect.com/science/ar…
Waiel Abusnina (وائل أبوسنينة) retweeted
🚀 Thrilled to share that our study—the first real-world analysis of adverse events reported for the Evoque transcatheter tricuspid valve replacement—has just been published in JACC: Cardiovascular Interventions!
lnkd.in/e3VqU5Vg
Using the FDA MAUDE database, we reviewed every report filed in the first year after approval (2 Feb 2024 – 1 Feb 2025) and uncovered several adverse events never observed in the pivotal trial.
Two notable examples:
• Device malposition / migration / embolization – the second most common event; likely linked to early operator learning curves and a broader, less-selected patient spectrum.
• Nose-cone detachment – 4 reports (2.5 %) hint at a potential device-integrity issue that calls for investigation and operator vigilance.
Snapshot of 158 reported events
(percent of reports; true incidence unknown)
1️⃣ AV block / bradycardia – 44.3 %
2️⃣ Malposition / migration / embolization – 20.9 %
3️⃣ Leaflet thrombosis – 12.7 %
4️⃣ Cardiac tamponade – 5.1 %
5️⃣ Venous injury / bleeding – 5.1 %
6️⃣ Arrhythmia / cardiac arrest – 3.2 %
7️⃣ Delivery-catheter failure (nose-cone) – 2.5 %
Take-home: Early signals stress the importance of careful patient selection, meticulous implantation technique, and ongoing post-market surveillance as Evoque adoption grows.
🙏 Heartfelt thanks to my amazing co-authors—Toby Rogers, @haberdan, Matteo Cellamare, @KalChitturi, @IAmDoctorAbhi, @wabusnina, Itsik Ben-Dor, Lowell Satler, and @ronwaksman—for their guidance, support, and hard work on this project!
#Evoque #TTVR #StructuralHeart #MAUDE #JACCInterventions #CardioTwitter @JACCJournals
A highly practical manuscript 📄focused on closure device-related complications💉, led by @haberdan 🌟
When closure becomes complication:
7 cases of Perclose-induced CFA occlusion post-TAVR managed percutaneously with cutting balloon angioplasty. Benchtop model confirms mechanism.
No surgery. No reintervention.
🧠💡
🔗 DOI: 10.1002/ccd.31598
#TAVR #VCD #CardioTwitter
1
350
Waiel Abusnina (وائل أبوسنينة) retweeted
#CRT2025 was a great success. Catch up on all the Late-Breaking Clinical Trials @CRT_meeting @jgalo92 @IAmDoctorAbhi @wabusnina @baileysalimes @HayderHashim @CRMjournal
The CRT 2025 Late-Breaking Trials summary is now available online:
sciencedirect.com/science/ar…
@ronwaksman @BCase07 @CRT_meeting
Excited 🌟 to share our two recent publications 📄📚from our large health system database at MedStar Washington Hospital Center! 🏥 @MedStarResearch @GTCardFellows @CRT_meeting #cangrelor #cardiology
✅ Gender Disparities in Cangrelor Usage For The Treatment of Patients with ACS undergoing PCI @ccijournal
✅ Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With ACS Undergoing PCI @IJCardio
Key findings 📊: Women received less Cangrelor and had higher by TIMI major 🩸(no impact on MACE). No racial disparities in use or bleeding risk (AA vs. Caucasian). @ACCinTouch
doi.org/10.1016/j.ijcard.202…
doi.org/10.1002/ccd.31442
Waiel Abusnina (وائل أبوسنينة) retweeted
Our comprehensive guide recently published in @ccijournal outlines a systematic approach to evaluating CMD, emphasizing practical steps and troubleshooting strategies with case examples to ensure accurate measurements in your real world practice.
onlinelibrary.wiley.com/doi/…
The official opening of #CRT2025 🫀 at Washington, DC. Get ready for four days of in-depth education sessions and cutting-edge innovations 👩🔬👨🔬 @CRT_meeting #cardiology
Waiel Abusnina (وائل أبوسنينة) retweeted
Our results from CMDR suggest a strong association between epicardial fat volume index (a significant risk factor) and the presence of CMD. @wabusnina @IlanMerdler @IAmDoctorAbhi @lior_lupu @haberdan @DorBen @ron_waksman @HashimHayder @JAHA_AHA
ahajournals.org/doi/10.1161/…
Does epicardial fat play a role in coronary microvascular dysfunction (CMD)? 🤔Our new study suggests a link between increased epicardial fat index and CMD. More studies needed, but our research could be a key to better CMD diagnosis & treatment!
doi.org/10.1161/JAHA.124.038…
#cardiology #CMD #CardioTwitter #MustRead @ACCinTouch @GTCardFellows
@BCaseMD1 @KalChitturi @IAmDoctorAbhi @lior_lupu @haberdan @HashimHayder @DorBen @MedStarWHC @JAHA_AHA




















